Financial Daily from THE HINDU group of publications
Thursday, Jun 09, 2005
Financial Daily from THE HINDU group of publications Thursday, Jun 09, 2005 |
|
|
|
|
|
Corporate
-
Announcements Marketing - New Products & Services New allergy pill from Panacea Our Bureau
NEW DELHI: Panacea Biotec has launched a new anti-allergy drug, Ralif (rupatadine 10 mg) for conditions such as seasonal and perennial allergic rhinitis. Ralif, an oral, non-sedating drug, provides relief by inhibiting histamine and platelet activating factor (PAF), which are the most common mediators in allergic rhinitis whose symptoms include sleeplessness, fatigue and irritability. Mr Rajesh Jain, Joint Managing Director, Panacea Biotec Ltd, said, "This is part of our continuous effort to provide innovative, yet affordable drug therapies. Ralif has a dual mechanism which provides better relief from both allergy and associated inflammation, while other available medications have antihistaminic property only."
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2005, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|